Generate QR code
Open Access
Subscription Access
Features of the course of the new coronavirus infection in patients with bronchial asthma and allergic reactions
https://doi.org/10.30629/0023-2149-2025-103-12-885-892
Abstract
The high pathogenicity of SARS-CoV-2 and the airborne transmission mechanism are a public health concern. At first, it was believed that a history of allergic reactions aggravated the course of the disease. Later, it turned out that bronchial asthma (BA) in patients or other allergic diseases did not affect the severity of coronavirus infection (CVI).
Objective. The aim of the study is to identify the relationship between the course of COVID-19 in patients with asthma and allergies.
Material and methods. As a result of the cross-sectional study of the hypothesis, a retrospective analysis of people was conducted for the years 2019–2023. The study group — patients with confirmed COVID-19 and the presence of dispensary registration for bronchial asthma, patients with confirmed COVID-19 and a history of allergies. To assess the severity of the disease, laboratory parameters of patients in dynamics and symptoms were taken.
Results. Women with COVID-19 have lower ESR levels than women with concomitant asthma and allergies; men have identical results. The CRP indicators in women with an aggravated anamnesis increase sharply, in contrast to individuals with COVID-19. In men, no significant differences in the CRP results were found.
Conclusion. In women and men with bronchial asthma and/or a history of allergies, the course of COVID-19 was milder, both according to laboratory data and the corresponding clinical picture.
About the Authors
A. S. Tambovskaya
Tula State University
Russian Federation
Russian Federation
Anastasia S. Tambovskaya — 6th year student
Tula
V. A. Klyukina
Tula State University
Russian Federation
Russian Federation
Valeria A. Klyukina — 6th year student
Tula
S. G. Nekhaev
Tula State University
Russian Federation
Russian Federation
Sergey G. Nekhaev — Candidate of Medical Sciences, Associate Professor of the Department of Infectious Diseases
Tula
References
1. Kolifarhood G., Aghaali M., Mozafar Saadati H., Taherpour N., Rahimi S., Izadi N. et al. Epidemiological and clinical aspects of COVID-19; a narrative review. Arch. Acad. Emerg. Med. 2020;8(1):e41. URL: https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/620
2. Sunjaya A.P., Allida S.M., Di Tanna G.L., Jenkins C. Asthma and risk of infection, hospitalisation, ICU admission and mortality from COVID-19: systematic review and meta-analysis. J. Asthma. 2021;8:1–22. DOI: 10.1080/02770903.2021.1888116
3. Romanov B.S. Coronavirus infection Covid-19. Safety and risk of pharmacotherapy. 2020;8(1):3– 8. (In Russian). DOI: 10.30895/2312-7821-2020-8-1-3-8
4. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–42. URL: https://jamanetwork.com/journals/jama/fullarticle/2762130?resultClick=1
5. Lepiller Q., Barth H., Lefebvre F., Herbrecht R., Lutz P., Kessler R. et al. High incidence but low burden of coronaviruses and preferential associations between respiratory viruses. J Clin Microbiol. 2013;51:3039–46. URL: https://journals.asm.org/doi/10.1128/jcm.01078-13
6. Lombardi C., Gani F., Berti A. et al. Asthma and COVID-19: a dangerous liaison? Asthma Res. Pract. 2021;7(1):9. DOI: 10.1186/s40733-021-00075-z
7. Trukhan D.I. New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions. Meditsinskiy sovet. 2022;16(18):154-161. (In Russian). DOI: 10.21518/2079-701Х-2022-16-18-154-161
8. Liu S., Cao Y., Du T., Zhi Y. Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and metaanalysis. J. Allergy Clin. Immunol. Pract. 2021;9(2):693–701. DOI: 10.1016/j.jaip.2020.11.054
9. Murillo-Zamora E. Hernandez-Suarez C.M. Survival in adult inpatients with COVID-19. Public Health. 2021;190:1–3. DOI: 10.1016/j.puhe.2020.10.029
10. Sycheva A.S., Kebina A.L., Vërtkin A.L. Clinical and prognostic criteria for the complicated course of a new coronavirus infection (COVID-19). Mediko-farmatsevticheskiy zhurnal Puls. 2021;9 (23)147–153. (In Russian). DOI: 10.26787/nydha-2686-6838-2021-23-9-147-153
11. Kuzubova N. A., Titova O. N., Lebedeva E. S., Volchkova E. V. Endothelial progenitor cells in the pathogenesis of a new coronavirus infection. Meditsinskiy sovet. 2021;(4):199–204. (In Russian). DOI: 10.21518/2079-701Х-2021-4-199-204
12. Baklaushev V.P., Kulemzin S.V., Gorchakov A.A., Yusubalieva G.M., Lesnyak V.N., Sotnikova A.G. Covid-19. Etiology, pathogene sis, diagnosis and treatment. Clinical practice. 2020:10. (In Russian).
13. Novikova V.I., Novikov P.D., Titova N.D. Heterogeneity of allergy in bronchial asthma in children. Bulletin of VSMU. 2014;4:111–114. (In Russian). URL: https://vestnik.vsmu.by/archive/2014/13-4/2014-4-110-116.html
14. Novak N., Cabanillas B. Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2. Immunology. 2020;161(2):83–93. DOI: 10.1111/imm.13240
15. Khlodova L.G. Bronchial asthma and covid-19 // Asthma and allergy. 2020;1:3–5. (In Russian). URL: https://cyberleninka.ru/article/n/bronhialnaya-astma-i-covid-19/viewer
16. Carli G. Cecchi L. Stebbing J. et al. Is asthma protective against COVID-19? Allergy. 2020. DOI: 10.1111/all.14426
17. Peters M.C., Sajuthi S., Deford P. et al. COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am. J. Respir. Crit. Care Med. 2020;202(1):83–90. DOI: 10.1164/rccm.202003-0821OC
18. Abbafati C., Abbas K.M., Abbasi M.et al. Global burden of 369 discases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 2020;396(10258):1204–1222. DOI: 10.1016/S0140-6736(20)30925-9
19. Federal State Budgetary Institution “TsNIIOIZ” of the Ministry of Health of the Russian Federation. Main page. (n.d.). Retrieved February 9, 2024, (In Russian). from https://mednet.ru/
Review
For citations:
Tambovskaya A.S., Klyukina V.A., Nekhaev S.G. Features of the course of the new coronavirus infection in patients with bronchial asthma and allergic reactions. Clinical Medicine (Russian Journal). 2025;103(12):885-892. (In Russ.) https://doi.org/10.30629/0023-2149-2025-103-12-885-892
Views:
171
JATS XML
Email this article 